Cargando…

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Triple-negative breast cancer (TNBC) is a collection of biologically diverse cancers characterized by distinct transcriptional patterns, biology, and immune composition. TNBCs subtypes include two basal-like (BL1, BL2), a mesenchymal (M) and a luminal androgen receptor (LAR) subtype. Through a compr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehmann, Brian D., Colaprico, Antonio, Silva, Tiago C., Chen, Jianjiao, An, Hanbing, Ban, Yuguang, Huang, Hanchen, Wang, Lily, James, Jamaal L., Balko, Justin M., Gonzalez-Ericsson, Paula I., Sanders, Melinda E., Zhang, Bing, Pietenpol, Jennifer A., Chen, X. Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560912/ https://www.ncbi.nlm.nih.gov/pubmed/34725325 http://dx.doi.org/10.1038/s41467-021-26502-6

Ejemplares similares

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

LR Hunting: A Random Forest Based Cell–Cell Interaction Discovery Method for Single-Cell Gene Expression Data
por: Lu, Min, et al.
Publicado: (2021)

PathwayMultiomics: An R Package for Efficient Integrative Analysis of Multi-Omics Datasets With Matched or Un-matched Samples
por: Odom, Gabriel J., et al.
Publicado: (2021)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
por: Lehmann, Brian D, et al.
Publicado: (2014)

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Tissue-specific expression of p73 and p63 isoforms in human tissues
por: Marshall, Clayton B., et al.
Publicado: (2021)

Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities
por: Kordias, Dimitris, et al.
Publicado: (2022)

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance
por: James, Jamaal L, et al.
Publicado: (2023)

Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS
por: Lee, Hojae, et al.
Publicado: (2021)

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
por: Jovanović, Bojana, et al.
Publicado: (2017)

MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression
por: Franklin, Derek A., et al.
Publicado: (2020)

Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Osteosarcoma Multi-Omics Landscape and Subtypes
por: Tang, Shan, et al.
Publicado: (2023)

How interacting pathways are regulated by miRNAs in breast cancer subtypes
por: Cava, Claudia, et al.
Publicado: (2016)

Simultaneous Interrogation of Cancer Omics to Identify Subtypes With Significant Clinical Differences
por: Xu, Aodan, et al.
Publicado: (2019)

Detecting molecular subtypes from multi-omics datasets using SUMO
por: Sienkiewicz, Karolina, et al.
Publicado: (2022)

Consensus clustering applied to multi-omics disease subtyping
por: Brière, Galadriel, et al.
Publicado: (2021)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Integrated Multiple “-omics” Data Reveal Subtypes of Hepatocellular Carcinoma
por: Liu, Gang, et al.
Publicado: (2016)

NEMO: cancer subtyping by integration of partial multi-omic data
por: Rappoport, Nimrod, et al.
Publicado: (2019)

Multi-omics subtyping pipeline for chronic obstructive pulmonary disease
por: Gillenwater, Lucas A., et al.
Publicado: (2021)

omicsGAT: Graph Attention Network for Cancer Subtype Analyses
por: Baul, Sudipto, et al.
Publicado: (2022)

Functional impact of multi-omic interactions in breast cancer subtypes
por: Ochoa, Soledad, et al.
Publicado: (2023)

Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
por: Luo, Na, et al.
Publicado: (2018)

MOCSS: Multi-omics data clustering and cancer subtyping via shared and specific representation learning
por: Chen, Yuxin, et al.
Publicado: (2023)

Multi-omics analysis reveals CLIC1 as a therapeutic vulnerability of gliomas
por: Wang, Chengcheng, et al.
Publicado: (2023)

p73 regulates epidermal wound healing and induced keratinocyte programming
por: Beeler, J. Scott, et al.
Publicado: (2019)

Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data
por: Zhang, Zhe, et al.
Publicado: (2016)

Multi-Omics Analysis Reveals Novel Subtypes and Driver Genes in Glioblastoma
por: Yuan, Yang, et al.
Publicado: (2020)

Evaluation and comparison of multi-omics data integration methods for cancer subtyping
por: Duan, Ran, et al.
Publicado: (2021)

A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes
por: Menden, Kevin, et al.
Publicado: (2023)

Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
por: Chen, Hsin-Chih, et al.
Publicado: (2022)

Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use
por: Kolli, Udhghatri, et al.
Publicado: (2023)

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer
por: Jovanović, Bojana, et al.
Publicado: (2014)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer
por: Evans, Kurt W., et al.
Publicado: (2021)

OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines
por: Cotugno, Nicola, et al.
Publicado: (2019)

Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas
por: Hou, Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b5eapa97i8qm7unaqa1kap6rvb